Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
American Society of Clinical Oncology to hold a symposium » 08:12
01/23/20
01/23
08:12
01/23/20
08:12
AMZN

Amazon.com

$1,887.32 /

-4.96 (-0.26%)

, AGIO

Agios Pharmaceuticals

$53.80 /

+0.01 (+0.02%)

, AZN

AstraZeneca

$50.45 /

-0.345 (-0.68%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$67.42 /

-0.01 (-0.01%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, DSNKY

Daiichi Sankyo

$0.00 /

+ (+0.00%)

, ERYP

Erytech Pharma

$7.23 /

+ (+0.00%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, EXEL

Exelixis

$19.72 /

-0.04 (-0.20%)

, FGEN

FibroGen

$43.78 /

+0.8 (+1.86%)

, HSDEF

Harborside

$0.00 /

+ (+0.00%)

, INCY

Incyte

$78.47 /

-0.22 (-0.28%)

, LXRX

Lexicon

$3.77 /

-0.28 (-6.91%)

, MRK

Merck

$89.65 /

-0.31 (-0.34%)

, NTRA

Natera

$37.16 /

+0.01 (+0.03%)

, NVTA

Invitae

$18.77 /

-0.025 (-0.13%)

, PFE

Pfizer

$40.19 /

-0.17 (-0.42%)

, PGNX

Progenics

$4.67 /

+0.015 (+0.32%)

, SGEN

Seattle Genetics

$111.71 /

+3.04 (+2.80%)

, TROV

Trovagene

$1.73 /

+0.18 (+11.61%)

2020 Gastrointestinal…

2020 Gastrointestinal Cancers Symposium will be held in San Francisco on January 23-25.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Wednesday
Conference/Events
North American Veterinary Community to hold a meeting & expo » 04:55
01/22/20
01/22
04:55
01/22/20
04:55
BDX

Becton Dickinson

$277.51 /

+0.375 (+0.14%)

, CHWY

Chewy

$30.14 /

+0.765 (+2.60%)

, COF

Capital One

$102.29 /

-1.85 (-1.78%)

, CVET

Covetrus

$15.10 /

+0.08 (+0.53%)

, ELAN

Elanco

$30.64 /

+0.65 (+2.17%)

, HRC

Hill-Rom

$115.16 /

-0.6 (-0.52%)

, HSKA

Heska

$105.90 /

-1.76 (-1.63%)

, IDXX

Idexx Laboratories

$284.74 /

-0.96 (-0.34%)

, KIN

Kindred Biosciences

$9.81 /

-0.04 (-0.41%)

, MASI

Masimo

$173.64 /

+3.725 (+2.19%)

, MRK

Merck

$89.96 /

-1.02 (-1.12%)

, O

Realty Income

$77.73 /

+1.39 (+1.82%)

, PDCO

Patterson Companies

$23.71 /

+0.43 (+1.85%)

, SKX

Skechers

$41.21 /

-0.69 (-1.65%)

, SSNLF

Samsung

$0.00 /

+ (+0.00%)

, TECH

Bio-Techne

$221.53 /

+1.08 (+0.49%)

, TRUP

Trupanion

$31.95 /

-0.86 (-2.62%)

, UCBI

United Community Banks

$29.75 /

-0.6 (-1.98%)

, WFC

Wells Fargo

$48.95 /

-0.23 (-0.47%)

, XRAY

Dentsply Sirona

$60.33 /

+0.36 (+0.60%)

, ZTS

Zoetis

$141.90 /

+1.75 (+1.25%)

Veterinary Meeting &…

Veterinary Meeting & Expo: VMX 2020 will be held in Orlando on January 18-22.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23
    Jan
Tuesday
Conference/Events
North American Veterinary Community to hold a meeting & expo » 07:59
01/21/20
01/21
07:59
01/21/20
07:59
BDX

Becton Dickinson

$277.14 /

+0.205 (+0.07%)

, CHWY

Chewy

$29.37 /

+0.065 (+0.22%)

, COF

Capital One

$104.14 /

+1.25 (+1.21%)

, CVET

Covetrus

$15.02 /

+0.11 (+0.74%)

, ELAN

Elanco

$29.99 /

-0.62 (-2.03%)

, HRC

Hill-Rom

$115.76 /

-0.38 (-0.33%)

, HSKA

Heska

$107.66 /

+1.38 (+1.30%)

, IDXX

Idexx Laboratories

$285.70 /

-3.98 (-1.37%)

, KIN

Kindred Biosciences

$9.85 /

-0.4 (-3.90%)

, MASI

Masimo

$169.91 /

+0.08 (+0.05%)

, MRK

Merck

$90.98 /

-0.2 (-0.22%)

, O

Realty Income

$76.34 /

+0.18 (+0.24%)

, PDCO

Patterson Companies

$23.28 /

-0.44 (-1.85%)

, SKX

Skechers

$41.90 /

-1.08 (-2.51%)

, SSNLF

Samsung

$0.00 /

+ (+0.00%)

, TECH

Bio-Techne

$220.45 /

+1.18 (+0.54%)

, TRUP

Trupanion

$32.81 /

+0.61 (+1.89%)

, UCBI

United Community Banks

$30.35 /

+0.19 (+0.63%)

, WFC

Wells Fargo

$49.18 /

-0.07 (-0.14%)

, XRAY

Dentsply Sirona

$59.97 /

-0.19 (-0.32%)

, ZTS

Zoetis

$140.15 /

+0.9 (+0.65%)

Veterinary Meeting &…

Veterinary Meeting & Expo: VMX 2020 will be held in Orlando on January 18-22.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Merck and AstraZeneca announces FDA accepted sNDA for Lynparza » 06:58
01/21/20
01/21
06:58
01/21/20
06:58
MRK

Merck

$90.98 /

-0.2 (-0.22%)

, AZN

AstraZeneca

$51.34 /

+0.84 (+1.66%)

AstraZeneca (AZN) and…

AstraZeneca (AZN) and Merck (MRK) announced that a supplemental New Drug Application, or sNDA, for LYNPARZA has been accepted and granted priority review by the FDA for the treatment of patients with metastatic castration-resistant prostate cancer, or mCRPC, and deleterious or suspected deleterious germline or somatic homologous recombination repair, or HRR, gene mutations, who have progressed following prior treatment with a new hormonal agent. A Prescription Drug User Fee Act, or PDUFA, date is set for the second quarter of 2020. The sNDA acceptance for review by the FDA is based on positive results from the Phase 3 PROfound trial, which were presented during a Presidential Symposium at the 2019 European Society of Medical Oncology congress.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
EBDF Group to hold a conference » 04:55
01/15/20
01/15
04:55
01/15/20
04:55
A

Agilent

$88.02 /

+0.565 (+0.65%)

, AGE

A.G. Edwards

$1.85 /

+0.13 (+7.56%)

, ALNY

Alnylam

$118.48 /

+3.68 (+3.21%)

, AZN

AstraZeneca

$50.18 /

+0.5 (+1.01%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.34 /

-0.04 (-0.91%)

, ENTX

Entera Bio

$2.78 /

-0.03 (-1.07%)

, DYAI

Dyadic International

$5.50 /

-0.135 (-2.40%)

, DTIL

Precision BioSciences

$13.40 /

-0.12 (-0.89%)

, DD

DuPont

$60.16 /

-0.25 (-0.41%)

, CYCC

Cyclacel Pharmaceuticals

$0.74 /

-0.0549 (-6.91%)

, CTLT

Catalent

$60.34 /

+0.88 (+1.48%)

, COWN

Cowen Group

$16.34 /

-0.2 (-1.21%)

, GMAB

Genmab

$22.44 /

-0.21 (-0.93%)

, IDXG

Interpace Biosciences

$0.62 /

+ (+0.00%)

, LCTX

Lineage Cell Therapeutics

$0.75 /

-0.0146 (-1.92%)

, PHIO

Phio Pharmaceuticals

$0.20 /

+0.0117 (+6.35%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.48 /

+0.03 (+2.07%)

, TROV

Trovagene

$1.47 /

+0.15 (+11.41%)

, VCYT

Veracyte

$28.58 /

+0.17 (+0.60%)

, VIE

Viela Bio

$37.10 /

+4.17 (+12.66%)

, PSTV

Plus Therapeutics

$2.81 /

+0.02 (+0.72%)

, RDUS

Radius Health

$20.14 /

+1.77 (+9.64%)

, MRNA

Moderna

$20.01 /

-0.21 (-1.04%)

, MRK

Merck

$89.93 /

+0.5 (+0.56%)

, NAVB

Navidea

$1.49 /

-0.03 (-1.97%)

, NBSE

NeuBase Therapeutics

$6.31 /

-0.19 (-2.92%)

, NVO

Novo Nordisk

$59.62 /

+0.66 (+1.12%)

, NVS

Novartis

$94.47 /

+0.765 (+0.82%)

, OVID

Ovid Therapeutics

$3.59 /

+0.09 (+2.57%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$7.20 /

+0.46 (+6.82%)

, SLRX

Salarius Pharmaceuticals

$3.20 /

+0.15 (+4.92%)

, VVUS

VIVUS

$2.72 /

-0.01 (-0.37%)

, SIVB

SVB Financial

$253.42 /

-0.36 (-0.14%)

, VRML

Vermillion

$0.79 /

-0.0453 (-5.39%)

, VKTX

Viking Therapeutics

$7.36 /

+0.045 (+0.62%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
EBDF Group to hold a conference » 04:55
01/14/20
01/14
04:55
01/14/20
04:55
A

Agilent

$87.45 /

-0.19 (-0.22%)

, AGE

A.G. Edwards

$1.72 /

-0.15 (-8.02%)

, ALNY

Alnylam

$114.80 /

-4.57 (-3.83%)

, AZN

AstraZeneca

$49.68 /

-0.17 (-0.34%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.38 /

+0.01 (+0.23%)

, ENTX

Entera Bio

$2.81 /

+0.13 (+4.85%)

, DYAI

Dyadic International

$5.64 /

-0.055 (-0.97%)

, DTIL

Precision BioSciences

$13.52 /

-1.19 (-8.09%)

, DD

DuPont

$60.41 /

+0.7 (+1.17%)

, CYCC

Cyclacel Pharmaceuticals

$0.80 /

-0.115 (-12.64%)

, CTLT

Catalent

$59.46 /

+1.77 (+3.07%)

, COWN

Cowen Group

$16.54 /

+0.24 (+1.47%)

, GMAB

Genmab

$22.65 /

-0.02 (-0.09%)

, IDXG

Interpace Biosciences

$0.62 /

-0.0289 (-4.45%)

, LCTX

Lineage Cell Therapeutics

$0.76 /

-0.002 (-0.26%)

, PHIO

Phio Pharmaceuticals

$0.18 /

-0.0225 (-10.95%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.45 /

-0.14 (-8.81%)

, TROV

Trovagene

$1.32 /

+0.075 (+6.05%)

, VCYT

Veracyte

$28.41 /

-0.49 (-1.70%)

, VIE

Viela Bio

$32.93 /

+2.84 (+9.44%)

, PSTV

Plus Therapeutics

$2.79 /

-0.05 (-1.76%)

, RDUS

Radius Health

$18.37 /

-1.05 (-5.41%)

, MRNA

Moderna

$20.22 /

+1.12 (+5.86%)

, MRK

Merck

$89.43 /

-0.08 (-0.09%)

, NAVB

Navidea

$1.52 /

+ (+0.00%)

, NBSE

NeuBase Therapeutics

$6.50 /

-0.51 (-7.28%)

, NVO

Novo Nordisk

$58.96 /

+0.27 (+0.46%)

, NVS

Novartis

$93.71 /

-0.165 (-0.18%)

, OVID

Ovid Therapeutics

$3.50 /

-0.35 (-9.09%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$6.74 /

+0.3 (+4.66%)

, SLRX

Salarius Pharmaceuticals

$3.05 /

-0.58 (-15.98%)

, VVUS

VIVUS

$2.73 /

-0.065 (-2.33%)

, SIVB

SVB Financial

$253.78 /

+1.99 (+0.79%)

, VRML

Vermillion

$0.84 /

+0.036 (+4.48%)

, VKTX

Viking Therapeutics

$7.31 /

-0.4 (-5.19%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
EBDF Group to hold a conference » 08:42
01/13/20
01/13
08:42
01/13/20
08:42
A

Agilent

$87.64 /

+0.32 (+0.37%)

, AGE

A.G. Edwards

$1.87 /

-0.01 (-0.53%)

, ALNY

Alnylam

$119.37 /

+1.36 (+1.15%)

, AZN

AstraZeneca

$49.85 /

-0.24 (-0.48%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.37 /

+0.02 (+0.46%)

, ENTX

Entera Bio

$2.68 /

+0.08 (+3.08%)

, DYAI

Dyadic International

$5.69 /

+0.36 (+6.75%)

, DTIL

Precision BioSciences

$14.71 /

+0.02 (+0.14%)

, DD

DuPont

$59.71 /

-1.25 (-2.05%)

, CYCC

Cyclacel Pharmaceuticals

$0.91 /

+0.1578 (+20.98%)

, CTLT

Catalent

$57.69 /

+0.73 (+1.28%)

, COWN

Cowen Group

$16.30 /

-0.25 (-1.51%)

, GMAB

Genmab

$22.67 /

+ (+0.00%)

, IDXG

Interpace Biosciences

$0.65 /

+0.0189 (+3.00%)

, LCTX

Lineage Cell Therapeutics

$0.76 /

-0.018 (-2.31%)

, PHIO

Phio Pharmaceuticals

$0.21 /

-0.023 (-9.83%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.59 /

+ (+0.00%)

, TROV

Trovagene

$1.24 /

-0.02 (-1.59%)

, VCYT

Veracyte

$28.90 /

+0.45 (+1.58%)

, VIE

Viela Bio

$30.09 /

+1.07 (+3.69%)

, PSTV

Plus Therapeutics

$2.84 /

+0.13 (+4.80%)

, RDUS

Radius Health

$19.42 /

-1.07 (-5.22%)

, MRNA

Moderna

$19.10 /

+0.71 (+3.86%)

, MRK

Merck

$89.51 /

+0.11 (+0.12%)

, NAVB

Navidea

$1.52 /

+0.005 (+0.33%)

, NBSE

NeuBase Therapeutics

$7.01 /

-0.36 (-4.88%)

, NVO

Novo Nordisk

$58.69 /

+1.25 (+2.18%)

, NVS

Novartis

$93.87 /

-0.88 (-0.93%)

, OVID

Ovid Therapeutics

$3.85 /

-0.18 (-4.47%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$6.44 /

+0.14 (+2.22%)

, SLRX

Salarius Pharmaceuticals

$3.63 /

+0.03 (+0.83%)

, VVUS

VIVUS

$2.79 /

-0.03 (-1.06%)

, SIVB

SVB Financial

$251.79 /

-4.15 (-1.62%)

, VRML

Vermillion

$0.80 /

-0.016 (-1.95%)

, VKTX

Viking Therapeutics

$7.71 /

-0.02 (-0.26%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Merck,AstraZeneca: FDA accepts sNDA for LYNPARZA/ bevacizumab » 06:57
01/13/20
01/13
06:57
01/13/20
06:57
MRK

Merck

$89.51 /

+0.11 (+0.12%)

, AZN

AstraZeneca

$49.85 /

-0.24 (-0.48%)

AstraZeneca (AZN) and…

AstraZeneca (AZN) and Merck (MRK) announced that a supplemental New Drug Application for LYNPARZA in combination with bevacizumab has been accepted and granted priority review by the U.S. FDA for the maintenance treatment of women with advanced ovarian cancer whose disease showed a complete or partial response to first-line treatment with platinum-based chemotherapy and bevacizumab. A Prescription Drug User Fee Act date is set for the second quarter of 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
AstraZeneca, Merck say Lynparza submission granted priority review in the U.S. » 06:40
01/13/20
01/13
06:40
01/13/20
06:40
AZN

AstraZeneca

$49.85 /

-0.24 (-0.48%)

, MRK

Merck

$89.51 /

+0.11 (+0.12%)

AstraZeneca (AZN) and…

AstraZeneca (AZN) and Merck & Co (MRK) announced that a supplemental New Drug Application for Lynparza in combination with bevacizumab has been accepted and granted Priority Review in the US for the maintenance treatment of patients with advanced ovarian cancer who are in complete or partial response to 1st-line platinum-based chemotherapy with bevacizumab. A Prescription Drug User Fee Act date is set for the second quarter of 2020. The Priority Review by the US Food and Drug Administration was based on results from the pivotal Phase III PAOLA-1 trial, which were published in The New England Journal of Medicine. The trial compared Lynparza when added to standard-of-care bevacizumab vs. bevacizumab alone in patients with advanced ovarian cancer in the 1st-line maintenance setting, regardless of their biomarker status or outcome from previous surgery. The investigator-assessed results showed Lynparza added to bevacizumab reduced the risk of disease progression or death by 41% based on a hazard ratio of 0.59 and improved progression-free survival to a median of 22.1 months vs. 16.6 months for patients treated with bevacizumab alone. At two years after trial initiation, 46% of patients treated with Lynparza added to bevacizumab showed no disease progression vs. 28% of patients treated with bevacizumab alone. The safety and tolerability profiles of Lynparza and bevacizumab were consistent with previous trials for each medicine and showed no detriment to quality of life. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Immutep expands Part C of TACTI-002 following data » 08:21
01/09/20
01/09
08:21
01/09/20
08:21
IMMP

Immutep

$1.82 /

+0.01 (+0.55%)

, MRK

Merck

$88.61 /

-0.6 (-0.67%)

Immutep Limited (IMMP)…

Immutep Limited (IMMP) provides an update on its TACTI-002 and AIPAC studies for its lead product candidate, eftilagimod alpha. The requisite number of predefined patient responses was observed in stage 1 of Part C. The decision by the DMC to recommend opening stage 2 recruitment follows its review of preliminary safety and efficacy data and is based on a predefined efficacy threshold. This allows the Company to now proceed with the recruitment of an additional 19 patients, forming stage 2 of Part C of the study, having now also completed recruitment of the 18 HNSCC patients for stage 1. The staged approach to patient enrolment is based on the study's Simon's two-stage clinical trial design. Stage 1 of Part A was expanded in September 2019. Recruitment is ongoing for Part B with 10 out of 23 patients now participating, and for stage 2 of Part A, where 4 out of 19 patients are now participating. The Company expects to report more mature data from TACTI-002 in Q1 CY20. TACTI-002 is being conducted in collaboration with Merck & Co. (MRK). The Company continues to progress its AIPAC trial which evaluates efti in combination with chemotherapy in 227 metastatic breast cancer patients in a randomized, double blinded, placebo-controlled phase IIb clinical trial. The first progression-free survival read-out remains on track for Q1 CY20 and is expected to be reported in March 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.
友情链接:幸运飞艇官方开奖2020幸运飞艇计划网幸运飞艇走势图幸运飞艇历史开奖结果筛选